Full Title: Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen Recently, our first full scale GMP batch for an antisense oligonucleotide was manufactured in the newly built synthesis suite at Biogen. A four-step purification process was then carried out in the existing flexible volume manufacturing facility that, up until this point, has been used for manufacturing Biogen’s protein-based parenterals. This was our first test case to demonstrate that Biogen can manufacture ASOs safely, at scale, and achieve high purity and yield. Results are presented on the scalability of the ASO process from bench to GMP scale, highlighting successes and challenges faced with scale-up of the downstream ASO process.

Hora

15:00 - 16:00 hs GMT+1

Organizador

BioPharma Asia Magazine
Compartir
Enviar a un amigo
Mi email *
Email destinatario *
Comentario *
Repite estos números *
Control de seguridad
Junio / 2020 910 webinars
Lunes
Martes
Miércoles
Jueves
Viernes
Sábado
Domingo
Lun 01 de Junio de 2020
Mar 02 de Junio de 2020
Mié 03 de Junio de 2020
Jue 04 de Junio de 2020
Vie 05 de Junio de 2020
Sáb 06 de Junio de 2020
Dom 07 de Junio de 2020
Lun 08 de Junio de 2020
Mar 09 de Junio de 2020
Mié 10 de Junio de 2020
Jue 11 de Junio de 2020
Vie 12 de Junio de 2020
Sáb 13 de Junio de 2020
Dom 14 de Junio de 2020
Lun 15 de Junio de 2020
Mar 16 de Junio de 2020